Mochi Health vs BreezeMeds: Live Video Visits or Lower Starting Prices?
Mochi Health vs BreezeMeds answers whether you value live video visits or clearer per-medication starting prices. Quick verdict: choose Mochi Health if you want live video visits with a doctor bookable in about 5 minutes and membership-plus-medication pricing starting from $99; choose BreezeMeds if you prioritize listed per-product starting prices such as semaglutide injection from $199 and visible oral options.
Mochi Health vs BreezeMeds: Overview of core differences
This comparison uses only captured provider facts. Mochi Health emphasizes synchronous live video visits with a licensed physician bookable in about 5 minutes and a membership-plus-medication model with pricing from $99/month and promotional 50% off the first month with code BESTWLHALFOFF. BreezeMeds emphasizes product-level starting prices—semaglutide injection from $199/mo, tirzepatide injection from $299, oral semaglutide and tirzepatide displayed from $399—and discreet home delivery with clinician-reviewed online intake. Treatment availability on BreezeMeds is subject to a licensed clinician determining medical appropriateness.
Distinctive differences we compare
- Consultation format: live video versus online intake/clinician review
- Pricing model: membership-plus-medication versus per-product starting prices
- Product types clearly listed: Mochi’s compounded and some branded mentions versus BreezeMeds’ injectable and oral GLP-1 options
- Regulatory and transparency notes about compounded products and eligibility
| Criteria | Mochi Health | BreezeMeds |
|---|---|---|
| Consultation format | Live video visits with a doctor, bookable in about 5 minutes | Online intake with clinician review; live video not listed |
| Pricing model | Membership-plus-medication; pricing starts from $99/month; 50% off first month with code BESTWLHALFOFF | Product-level starting prices shown (semaglutide injection from $199/mo; tirzepatide injection from $299) |
| Product options | Compounded semaglutide and tirzepatide, compounded oral semaglutide pill, other compounded oral options; some branded-price references captured | Semaglutide injection, tirzepatide injection, oral semaglutide and tirzepatide listed from $399 |
| Availability | Reliable GLP-1 prescription access in all 50 states claimed on landing page | Treatment available when a licensed clinician determines it is medically appropriate; state availability not fully detailed |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Medication-specific approval status must be confirmed; branded and compounded products are not interchangeable |
Consultation style and clinical interaction
Mochi Health: the defining feature is live synchronous video visits that let a licensed physician evaluate your case, answer questions, and explain treatment options in real time. The source states these visits are bookable in about 5 minutes and contrast with many competitors that use asynchronous text reviews.
BreezeMeds: the material captures an online intake and clinician review model. BreezeMeds emphasizes clinician-reviewed treatment and discreet home delivery, with treatment available only when a licensed clinician determines it is medically appropriate.
Pricing structure and transparency
Mochi Health uses a membership-plus-medication approach. The source lists membership-plus-medication pricing starting from $99/month, a promotional $39 first-month membership rate for new customers in some offers, and a 50% off first month code BESTWLHALFOFF. The captured content notes ongoing pricing varies by plan and medication.
BreezeMeds lists product starting prices such as semaglutide injection from $199/mo, tirzepatide injection from $299, and oral options from $399. The source also notes a $169 figure that is not clearly tied to a product and that fees and billing commitments were not fully visible.
Products, compounded options, and regulatory notes
Mochi lists several compounded options including compounded semaglutide starting at $60 and compounded tirzepatide starting at $90, plus a compounded oral semaglutide pill starting at $62 and other compounded oral medications. The source includes the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
BreezeMeds lists injectable and oral GLP-1 options and cautions that medication-specific approval status must be confirmed; it notes that branded and compounded products are not interchangeable. BreezeMeds also emphasizes discreet shipping.
Which to choose
Choose Mochi Health if you prioritize a synchronous live video conversation with a licensed physician bookable in about 5 minutes, membership-plus-medication pricing starting from $99/month, and 24/7 support and ongoing appointment availability as captured.
Choose BreezeMeds if you prioritize visible per-product starting prices such as semaglutide injection from $199 and clear listing of oral GLP-1 options, and if you will confirm clinician eligibility, total cost, renewal terms, and state availability before enrollment.
Both providers include regulatory cautions in the captured content: compounded medications are not FDA-approved and treatment is subject to clinician review where noted. Mochi Health vs BreezeMeds reflects these source-specific qualifiers.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
